Benzinga | Mar 10, 2021 04:10PM EST

Lexicon Pharmaceuticals Q4 EPS $(0.04) Beats $(0.28) Estimate, Sales $200.00K Beat $110.00K Estimate

Lexicon Pharmaceuticals (NASDAQ:LXRX) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.28) by 85.71 percent. This is a 91.67 percent increase over losses of $(0.48) per share from the same period last year. The company reported quarterly sales of $200.00 thousand which beat the analyst consensus estimate of $110.00 thousand by 81.82 percent. This is a 97.71 percent decrease over sales of $8.73 million the same period last year.